ArticleInvestigational new drugs2022

Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes.

Tinnabhop Santadkha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.